- Ivermectin does not prevent severe cases of Covid-19, according to a clinical trial conducted by the Institute of Clinical Research.
- Doctors who wish to use this drug will have to make an application for use in clinical trials.
- Medical practitioners warned not to prescribe Ivermectin for Covid-19 treatment.
Public Urged To Stop Using Ivermectin Illegally To Treat Covid
Following a clinical research that verified Ivermectin’s ineffectiveness against Covid-19, medical practitioners and members of the general public have been advised against using it to treat the disease.
According to The Star, Dr. Koh Kar Chai, president of the Malaysian Medical Association (MMA), said that any effort to purchase Ivermectin over the counter for use in treating Covid-19 would be illegal.
“Doctors who wish to use this drug will have to make an application for use in clinical trials,” he said.
Ivermectin, according to Dr. Koh, is a drug available in Malaysia for specific reasons that do not involve being a treatment option in the management of Covid-19.
Ivermectin does not prevent severe cases of Covid-19, according to a clinical trial conducted by the Institute of Clinical Research.
As a result, the Health Ministry declared on Wednesday that Ivermectin cannot be included in the current Covid-19 treatment guidelines.
According to the ministry, the anti-viral medicine Ivermectin should only be used in clinical trials with close supervision until further supporting data becomes available. It has been warned that medical practitioners should not prescribe it for Covid-19 treatment.
Prior to this, Dr. Koh said, advocates of Ivermectin believed that the anti-viral medicine would be successful against Covid-19.
However, the clinical trial demonstrated that this was not the case, he said.
“So there will be no attempt by the government to get the drug to be approved for use in Covid-19 unless there is new data supporting its use,” he added.
Datuk Dr Zainal Ariffin Omar, head of the Malaysian Public Health Physicians Association, said that there was no tangible proof to establish Ivermectin’s efficacy against Covid-19 when compared to normal treatment.
Although inclusion in the clinical recommendations for Covid-19 treatment is not suggested, he believes the drug should be used for research purposes with appropriate approvals.
“It should not be used for prescription or general usage, except as described in the approved label, like for animal diseases and certain anti-parasite treatments,” he said, adding that people should wait for larger studies incorporating Ivermectin.
source - the guardian
In a statement with The Star, Dr. Zainal Ariffin believes that additional information about the clinical study’s outcomes and methods should be made available for public access.
“In standard evidence-based medicine, we have to go through a rigorous process of technical evaluation and peer-reviewed publication before being accepted for meta-analysis,” he said.
For decades, Ivermectin has been used to treat head lice and river blindness in humans, as well as heartworms in animals. Various manufacturers continue to include warnings about its negative effects on their labeling.
Dr. Khor Swee Kheng, an independent health policy expert, said that Ivermectin had “no effect" on Covid-19 except for inducing diarrhoea.
He claims that Ivermectin is effective in treating river blindness, which affects 1.2 million people in tropical countries; filariasis, an infectious tropical disease caused by parasitic roundworms; and hookworm infections, which are common in areas with limited access to clean water and sanitation and affects 600 million people worldwide.
Amrahi Buang, president of the Malaysian Pharmacists Society, said that the clinical research results were compatible with those of previous studies in Brazil and Argentina, according to The Star.
“Finally, our studies show that Ivermectin is not recommended for treatment of Covid-19. Those who have been claiming otherwise should accept this. We hope people will stop using Ivermectin for Covid-19 immediately,” he said.
More in-depth research on Ivermectin, according to Amrahi, is welcome as long as suitable protocols are followed.